Meta-Analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer’s Disease

European Alzheimer's Disease Initiative (EADI), Lambert, Jean-Charles, Genetic and Environmental Risk in Alzheimer's Disease (GERAD), Alzheimer's Disease Genetic Consortium (ADGC), Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE), Ibrahim-Verbaas, Carla A, Harold, Denise, Naj, Adam C +178 more·2013·Nature Genetics

Cited by (1,086)

Items 501–600 of 1,086

  1. Genetic architecture of Alzheimer's disease
    Neuner, Sarah M., TCW, Julia, Goate, Alison M. · 2020 · Neurobiology of Disease
  2. Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review
    Rasmussen, Katrine Laura · 2016 · Atherosclerosis
  3. Epigenomics of Alzheimer's disease
    David Alan Bennett, Lei Yu, Jingyun Yang, Gyan Prakash Srivastava, Cristin Aubin, Philip L. De Jager · 2014 · Translational research
  4. Genetic risk factors for the posterior cortical atrophy variant of Alzheimer's disease
    Jonathan M. Schott, Sebastian James Crutch, Minerva M. Carrasquillo, James B. Uphill, Timothy J. Shakespeare, Natalie Sarah Ryan, Keir X. X. Yong, Manja Lehmann, Nilüfer Ertekin‐Taner, Neill R. Graff‐Radford et al. · 2016 · Alzheimer s & Dementia
  5. ABCA7 and Pathogenic Pathways of Alzheimer’s Disease
    Tomonori Aikawa, Marie‐Louise Holm, Takahisa Kanekiyo · 2018 · Brain Sciences
  6. Brain scans from 21,297 individuals reveal the genetic architecture of hippocampal subfield volumes
    Alzheimer’s Disease Neuroimaging Initiative, Dennis van der Meer, for the Pediatric Imaging, Neurocognition and Genetics Study, Jaroslav Rokicki, Tobias Kaufmann, Aldo Córdova‐Palomera, Torgeir Moberget, Dag Alnæs, Francesco Bettella, Oleksandr Frei et al. · 2018 · Molecular Psychiatry
  7. Endosomal Dysfunction Induced by Directly Overactivating Rab5 Recapitulates Prodromal and Neurodegenerative Features of Alzheimer’s Disease
    Anna Pensalfini, Seonil Kim, Shivakumar Subbanna, Cynthia Bleiwas, Chris N. Goulbourne, Philip H. Stavrides, Ying Jiang, Ju‐Hyun Lee, Sandipkumar Darji, Monika Pawlik et al. · 2020 · Cell Reports
  8. The Alzheimer’s gene SORL1 is a regulator of endosomal traffic and recycling in human neurons
    Swati Mishra, Allison Knupp, Marcell P. Szabo, Charles A. Williams, Chizuru Kinoshita, Dale W. Hailey, Yuliang Wang, Olav M. Andersen, Jessica E. Young · 2022 · Cellular and Molecular Life Sciences
  9. Significance of Complement System in Ischemic Stroke: A Comprehensive Review
    Yuanyuan Ma, Yanqun Liu, Zhijun Zhang, Guo‐Yuan Yang · 2019 · Aging and Disease
  10. Brain effective connectivity during motor-imagery and execution following stroke and rehabilitation
    Sahil Bajaj, Andrew J. Butler, Daniel F. Drake, Mukesh Dhamala · 2015 · NeuroImage Clinical
  11. The Alzheimer’s disease drug development landscape
    van Bokhoven, Pieter, de Wilde, Arno, Vermunt, Lisa, Leferink, Prisca S., Heetveld, Sasja, Cummings, Jeffrey, Scheltens, Philip, Vijverberg, Everard G. B. · 2021 · Alzheimer's Research & Therapy
  12. Missense variant in TREML2 protects against Alzheimer's disease
    Bruno A. Benítez, Sheng Chih Jin, Rita João Guerreiro, Rob Graham, Jenny Lord, Denise H. Harold, Rebecca Sims, Jean‐Charles Lambert, Jesse Raphael Gibbs, José Brás et al. · 2013 · Neurobiology of Aging
  13. Genetic architecture of epigenetic and neuronal ageing rates in human brain regions
    Ake Tzu-Hui Lu, Eilis J. Hannon, Morgan E. Levine, Eileen M. Crimmins, Katie Lunnon, Jonathan S. Mill, Daniel H. Geschwind, Steve Horvath · 2017 · Nature Communications
  14. Three-dimensional modeling of human neurodegeneration: brain organoids coming of age
    Karl Grenier, Jennifer Kao, Phedias Diamandis · 2019 · Molecular Psychiatry
  15. The epigenetic landscape of Alzheimer's disease
    Lord, Jenny, Cruchaga, Carlos · 2014 · Nature Neuroscience
  16. Cerebrospinal Fluid Biomarkers of Neurovascular Dysfunction in Mild Dementia and Alzheimer'S Disease
    Sweeney, Melanie D, Sagare, Abhay P, Zlokovic, Berislav V · 2015 · Journal of Cerebral Blood Flow & Metabolism
  17. The Role of PICALM in Alzheimer’s Disease
    Wei Xu, Lan Tan, Jin‐Tai Yu · 2014 · Molecular Neurobiology
  18. Genetic architecture of sporadic frontotemporal dementia and overlap with Alzheimer's and Parkinson's diseases
    Raffaele Ferrari, Yunpeng Wang, Jana Vandrovcová, Sebastian Guelfi, Aree Witeolar, Celeste M M. Karch, Andrew Joseph Schork, Chun Chieh Fan, James B. Brewer, International Genomics of Alzheimer's Project (IGAP), et al. · 2016 · Journal of Neurology Neurosurgery & Psychiatry
  19. SIRT1, miR-132 and miR-212 link human longevity to Alzheimer’s Disease
    Adva Hadar, Elena Milanesi, Marta Walczak, Monika Puzianowska‐Kuźnicka, Jacek Kuźnicki, Alessio Squassina, Paola Niola, Caterina Chillotti, Johannes Attems, Illana Gozes et al. · 2018 · Scientific Reports
  20. The amyloid cascade and Alzheimer's disease therapeutics: theory versus observation
    Rudy J. Castellani, Germán Plascencia‐Villa, George L. Perry · 2019 · Laboratory Investigation
  21. Inflammatory mechanisms in neurodegeneration
    Michael R. Nichols, Marie‐Kim St‐Pierre, Ann‐Christin Wendeln, Nyasha J. Makoni, Lisa K. Gouwens, Evan C. Garrad, Mona Sohrabi, Jonas J. Neher, Marie‐Ève Tremblay, Colin Kelly Combs · 2019 · Journal of Neurochemistry
  22. Phosphoinositides: Regulators of Nervous System Function in Health and Disease
    Padinjat Raghu, Annu Joseph, Harini Krishnan, Pramod Kumar Singh, Sankhanil Saha · 2019 · Frontiers in Molecular Neuroscience
  23. Microglia in neurodegenerative diseases
    Yu Xu, Ming-Zhu Jin, Zeyong Yang, Ming-Zhu Jin · 2020 · Neural Regeneration Research
  24. Shared Risk Factors between Dementia and Atherosclerotic Cardiovascular Disease
    Liv Tybjærg Nordestgaard, Mette Christoffersen, Ruth Frikke‐Schmidt · 2022 · International Journal of Molecular Sciences
  25. Associations of the Top 20 Alzheimer Disease Risk Variants With Brain Amyloidosis
    Liana G. Apostolova, Shannon L. Risacher, Tuğçe Duran, Eddie Stage, Naira Goukasian, John D. West, Triet M. Do, Jonathan F. Grotts, Holly M. Wilhalme, Kwangsik T. Nho et al. · 2018 · JAMA Neurology
  26. Parallel profiling of DNA methylation and hydroxymethylation highlights neuropathology-associated epigenetic variation in Alzheimer’s disease
    Adam R. Smith, Rebecca G. Smith, Ehsan Pishva, Eilis J. Hannon, Janou A. Y. Roubroeks, Joe Burrage, Claire Troakes, Safa Al‐Sarraj, Carolyn Sloan, Jonathan S. Mill et al. · 2019 · Clinical Epigenetics
  27. Gene therapy for Alzheimer’s disease targeting CD33 reduces amyloid beta accumulation and neuroinflammation
    Ana Griciuc, Anthony N. Federico, Jeya-shree Natasan, Angela M. Forte, Danielle McGinty, Huong Nguyen, Adrienn Volak, Stanley G. LeRoy, Sheetal Gandhi, Paul Lerner et al. · 2020 · Human Molecular Genetics
  28. Extracellular signal‐regulated kinase regulates microglial immune responses in Alzheimer’s disease
    Michael J. Chen, Supriya Ramesha, Laura D. Weinstock, Tianwen Gao, Lingyan Ping, Hailian Xiao, Eric B. Dammer, Duc D. Duong, Allan I. Levey, James J. Lah et al. · 2021 · Journal of Neuroscience Research
  29. Different effects of constitutive and induced microbiota modulation on microglia in a mouse model of Alzheimer’s disease
    Mezö, Charlotte, Dokalis, Nikolaos, Mossad, Omar, Staszewski, Ori, Neuber, Jana, Yilmaz, Bahtiyar, Schnepf, Daniel, de Agüero, Mercedes Gomez, Ganal-Vonarburg, Stephanie C., Macpherson, Andrew J. et al. · 2020 · Acta Neuropathologica Communications
  30. Identification of a protective microglial state mediated by miR-155 and interferon-γ signaling in a mouse model of Alzheimer’s disease
    Yin, Zhuoran, Herron, Shawn, Silveira, Sebastian, Kleemann, Kilian, Gauthier, Christian, Mallah, Dania, Cheng, Yiran, Margeta, Milica A., Pitts, Kristen M., Barry, Jen-Li et al. · 2023 · Nature Neuroscience
  31. Genetic diagnosis and prognosis of Alzheimer’s disease: challenges and opportunities
    Christiane Reitz · 2015 · Expert Review of Molecular Diagnostics
  32. Non-coding variability at the APOE locus contributes to the Alzheimer’s risk
    Zhou, Xiaopu, Chen, Yu, Mok, Kin Y., Kwok, Timothy C. Y., Mok, Vincent C. T., Guo, Qihao, Ip, Fanny C., Chen, Yuewen, Mullapudi, Nandita, Alzheimer’s Disease Neuroimaging Initiative et al. · 2019 · Nature Communications
  33. The Locus Coeruleus in Aging and Alzheimer’s Disease: A Postmortem and Brain Imaging Review
    Rebecca Beardmore, Ruihua H. Hou, Angela Darekar, Clive Holmes, Delphine Boche · 2021 · Journal of Alzheimer s Disease
  34. GBA and APOE Impact Cognitive Decline in Parkinson's Disease: A 10‐Year Population‐Based Study
    Aleksandra A. Szwedo, Ingvild Dalen, Kenn Freddy Pedersen, Marta Camacho, David C. Bäckström, Lars Forsgren, Charalampos Tzoulis, Sophie Winder‐Rhodes, Gavin Hudson, Ganqiang Liu et al. · 2022 · Movement Disorders
  35. Decoding microglial immunometabolism: a new frontier in Alzheimer's disease research
    Jung, Eun Sun, Choi, Hayoung, Mook-Jung, Inhee · 2025 · Molecular Neurodegeneration
  36. A comprehensive study of the genetic impact of rare variants in SORL1 in European early-onset Alzheimer’s disease
    Verheijen, Jan, Van den Bossche, Tobi, van der Zee, Julie, Engelborghs, Sebastiaan, Sanchez-Valle, Raquel, Lladó, Albert, Graff, Caroline, Thonberg, Håkan, Pastor, Pau, Ortega-Cubero, Sara et al. · 2016 · Acta Neuropathologica
  37. Alzheimer's Disease Mechanisms and Emerging Roads to Novel Therapeutics
    Sala Frigerio, Carlo, De Strooper, Bart · 2016 · Annual Review of Neuroscience
  38. Ultrastructural evidence of microglial heterogeneity in Alzheimer’s disease amyloid pathology
    El Hajj, Hassan, Savage, Julie C., Bisht, Kanchan, Parent, Martin, Vallières, Luc, Rivest, Serge, Tremblay, Marie-Ève · 2019 · Journal of Neuroinflammation
  39. SORL1 genetic variants and Alzheimer disease risk: a literature review and meta-analysis of sequencing data
    Campion, Dominique, Charbonnier, Camille, Nicolas, Gaël · 2019 · Acta Neuropathologica
  40. Traumatic Brain Injury Induces Genome-Wide Transcriptomic, Methylomic, and Network Perturbations in Brain and Blood Predicting Neurological Disorders
    Qingying Meng, Yumei Zhuang, Zhe Ying, Rahul Agrawal, Xia Yang, Fernando Gómez‐Pinilla · 2017 · EBioMedicine
  41. Differential associations of plasma lipids with incident dementia and dementia subtypes in the 3C Study: A longitudinal, population-based prospective cohort study
    Sabrina Schilling, Christophe Tzourio, Aïcha Soumaré, Sara Kaffashian, Jean‐François Dartigues, Marie‐Laure Ancelin, Cécilia Samieri, Carole Dufouil, Stéphanie Debette · 2017 · PLoS Medicine
  42. Integrated DNA methylation and gene expression profiling across multiple brain regions implicate novel genes in Alzheimer’s disease
    Stephen Andrew Semick, Rahul A. Bharadwaj, Leonardo Collado‐Torres, Ran Tao, Joo Heon Shin, Amy Deep‐Soboslay, James R. Weiss, Daniel R. Weinberger, Thomas M. Hyde, Joel E. Kleinman et al. · 2019 · Acta Neuropathologica
  43. Association of Early-Onset Alzheimer Disease With Elevated Low-Density Lipoprotein Cholesterol Levels and Rare Genetic Coding Variants of <i>APOB</i>
    Wingo, Thomas S., Cutler, David J., Wingo, Aliza P., Le, Ngoc-Anh, Rabinovici, Gil D., Miller, Bruce L., Lah, James J., Levey, Allan I. · 2019 · JAMA Neurology
  44. Genome-wide association studies for Alzheimer’s disease: bigger is not always better
    Escott-Price, Valentina, Hardy, John · 2022 · Brain Communications
  45. Functional screening of Alzheimer risk loci identifies PTK2B as an in vivo modulator and early marker of Tau pathology
    Dourlen, P, Fernandez-Gomez, F J, Dupont, C, Grenier-Boley, B, Bellenguez, C, Obriot, H, Caillierez, R, Sottejeau, Y, Chapuis, J, Bretteville, A et al. · 2017 · Molecular Psychiatry
  46. Systems-based proteomics to resolve the biology of Alzheimer’s disease beyond amyloid and tau
    Rayaprolu, Sruti, Higginbotham, Lenora, Bagchi, Pritha, Watson, Caroline M., Zhang, Tian, Levey, Allan I., Rangaraju, Srikant, Seyfried, Nicholas T. · 2021 · Neuropsychopharmacology
  47. Dementia-Related Adverse Events in PARADIGM-HF and Other Trials in Heart Failure with Reduced Ejection Fraction
    Jane A. Cannon, Li Shen, Pardeep S. Jhund, Søren Lund Kristensen, Lars Køber, Fabian Chen, Jianjian Gong, Martin P. Lefkowitz, Jean Lucien Rouleau, Victor Chengwei Shi et al. · 2016 · European Journal of Heart Failure
  48. Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLD
    Cyril P. Pottier, Yingxue Ren, Ralph B. Perkerson, Matt C. Baker, Gregory D. Jenkins, Marka van Blitterswijk, Mariely DeJesus‐Hernandez, Jeroen van Rooij, Melissa Erin Murray, Elizabeth A. Christopher et al. · 2019 · Acta Neuropathologica
  49. Dendritic Spines in Alzheimer’s Disease: How the Actin Cytoskeleton Contributes to Synaptic Failure
    Silvia Pelucchi, Ramona Stringhi, Elena E. Marcello · 2020 · International Journal of Molecular Sciences
  50. Discovery and validation of sub-threshold genome-wide association study loci using epigenomic signatures
    Xinchen Wang, Nathan R. Tucker, Gizem Rizki, Robert W. Mills, Peter H.L. Krijger, Elzo de Wit, Vidya Subramanian, Eric Bartell, Xinh-Xinh Nguyen, Jiangchuan Ye et al. · 2016 · eLife
  51. PRECISION MEDICINE - THE GOLDEN GATE FOR DETECTION, TREATMENT AND PREVENTION OF ALZHEIMER’S DISEASE
    Harald Juergen Hampel, Sid E. O’Bryant, Juan Ignacio Castrillo, Craig William Ritchie, Katrine Rojkova, Karl Broich, Norbert Benda, Robert Nisticò, Richard Frank, Bruno Dubois et al. · 2016 · The Journal of Prevention of Alzheimer s Disease
  52. Detecting Polygenic Adaptation in Admixture Graphs
    Fernando Racimo, Jeremy J. Berg, Joseph K. Pickrell · 2018 · Genetics
  53. Genome-wide association study of cerebral small vessel disease reveals established and novel loci
    Jaeyoon Chung, Sandro Marini, Joanna Pera, Bo Norrving, Jordi Jiménez-Conde, Jaume Roquer, Israel Fernández‐Cadenas, David Tirschwell, Magdy H. Selim, Devin L. Brown et al. · 2019 · Brain
  54. Genetically modified pig models for neurodegenerative disorders
    Ida E. Holm, Aage Kristian Olsen Alstrup, Yonglun Luo · 2015 · The Journal of Pathology
  55. Interpretable deep learning translation of GWAS and multi-omics findings to identify pathobiology and drug repurposing in Alzheimer’s disease
    Xu, Jielin, Mao, Chengsheng, Hou, Yuan, Luo, Yuan, Binder, Jessica L., Zhou, Yadi, Bekris, Lynn M., Shin, Jiyoung, Hu, Ming, Wang, Fei et al. · 2022 · Cell Reports
  56. Genetic risk for Alzheimer’s disease is concentrated in specific macrophage and microglial transcriptional networks
    Tansey, Katherine E., Cameron, Darren, Hill, Matthew J. · 2018 · Genome Medicine
  57. GEMC1 is a critical regulator of multiciliated cell differentiation
    Berta Terré, Gabriele Piergiovanni, Sandra Segura‐Bayona, Gabriel Gil‐Gómez, Sameh A. Youssef, Camille Stephan‐Otto Attolini, Michaela Wilsch‐Bräuninger, Carole Jung, Ana Maria Rojas, Marko Marjanović et al. · 2016 · The EMBO Journal
  58. Spatial and single-nucleus transcriptomic analysis of genetic and sporadic forms of Alzheimer’s disease
    Miyoshi, Emily, Morabito, Samuel, Henningfield, Caden M., Das, Sudeshna, Rahimzadeh, Negin, Shabestari, Sepideh Kiani, Michael, Neethu, Emerson, Nora, Reese, Fairlie, Shi, Zechuan et al. · 2024 · Nature Genetics
  59. Genetic risk for alzheimer disease is distinct from genetic risk for amyloid deposition
    Leonenko, Ganna, Shoai, Maryam, Bellou, Eftychia, Sims, Rebecca, Williams, Julie, Hardy, John, Escott‐Price, Valentina, the Alzheimer's Disease Neuroimaging Initiative · 2019 · Annals of Neurology
  60. Astrocytes as a Therapeutic Target in Alzheimer’s Disease–Comprehensive Review and Recent Developments
    Mateo Rodríguez-Giraldo, Rodrigo E. González-Reyes, Sofía Ramírez-Guerrero, Carlos E. Bonilla-Trilleras, Santiago Guardo-Maya, Mauricio O. Nava-Mesa · 2022 · International Journal of Molecular Sciences
  61. Genetically decreased vitamin D and risk of Alzheimer disease
    Lauren E. Mokry, Stephanie A. Ross, John A. Morris, Despoina Manousaki, Vincenzo Forgetta, John Brent Richards · 2016 · Neurology
  62. Toxoplasma Modulates Signature Pathways of Human Epilepsy, Neurodegeneration & Cancer
    Huân M. Ngô, Ying Zhou, Hernán Lorenzi, Kai Wang, Taek‐Kyun Kim, Yong Feng Zhou, Kamal El Bissati, Ernest J. Mui, Laura Fraczek, Seesandra V. Rajagopala et al. · 2017 · Scientific Reports
  63. Alzheimer's disease in the omics era
    Giulia Maria Sancesario, Sergio Bernardini · 2018 · Clinical Biochemistry
  64. Integrative genomics identifies a convergent molecular subtype that links epigenomic with transcriptomic differences in autism
    Ramaswami, Gokul, Won, Hyejung, Gandal, Michael J., Haney, Jillian, Wang, Jerry C., Wong, Chloe C. Y., Sun, Wenjie, Prabhakar, Shyam, Mill, Jonathan, Geschwind, Daniel H. · 2020 · Nature Communications
  65. Chronic consumption of a western diet induces robust glial activation in aging mice and in a mouse model of Alzheimer’s disease
    Leah C. Graham, Jeffrey M. Harder, Ileana Soto, Wilhelmine N. de Vries, Simon W. M. John, Gareth R. Howell · 2016 · Scientific Reports
  66. Genetics of neurodegenerative diseases: an overview
    Lasse Pihlstrøm, Sarah Wiethoff, Henry Houlden · 2017 · Handbook of clinical neurology
  67. Use of an Alzheimer’s disease polygenic risk score to identify mild cognitive impairment in adults in their 50s
    Mark W. Logue, Matthew S. Panizzon, Jeremy A. Elman, Nathan A. Gillespie, Sean N. Hatton, Daniel E. Gustavson, Ole A. Andreassen, Anders Martin Dale, Carol E. Franz, Michael J. Lyons et al. · 2018 · Molecular Psychiatry
  68. A genetic link between risk for Alzheimer's disease and severe COVID-19 outcomes via the <i>OAS1</i> gene
    Magusali, Naciye, Graham, Andrew C, Piers, Thomas M, Panichnantakul, Pantila, Yaman, Umran, Shoai, Maryam, Reynolds, Regina H, Botia, Juan A, Brookes, Keeley J, Guetta-Baranes, Tamar et al. · 2021 · Brain
  69. Telomere Length Shortening and Alzheimer Disease—A Mendelian Randomization Study
    Zhan, Yiqiang, Song, Ci, Karlsson, Robert, Tillander, Annika, Reynolds, Chandra A., Pedersen, Nancy L., Hägg, Sara · 2015 · JAMA Neurology
  70. Alzheimer’s disease risk polymorphisms regulate gene expression in the ZCWPW1 and the CELF1 loci
    Karch, Celeste M., Ezerskiy, Lubov A., Bertelsen, Sarah, Alzheimer’s Disease Genetics Consortium (ADGC), Goate, Alison M. · 2016 · PLoS ONE
  71. Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer’s disease with OSBPL6, PTPRG, and PDCL3
    Herold, C, Hooli, B V, Mullin, K, Liu, T, Roehr, J T, Mattheisen, M, Parrado, A R, Bertram, L, Lange, C, Tanzi, R E · 2016 · Molecular Psychiatry
  72. Stem-cell-derived human microglia transplanted into mouse brain to study human disease
    Nicola Fattorelli, Anna Martínez‐Muriana, Leen Wolfs, Ivana Geric, Bart De Strooper, Renzo Mancuso · 2021 · Nature Protocols
  73. Microglial efferocytosis: Diving into the Alzheimer’s disease gene pool
    Romero-Molina, Carmen, Garretti, Francesca, Andrews, Shea J., Marcora, Edoardo, Goate, Alison M. · 2022 · Neuron
  74. Genetic variability in response to amyloid beta deposition influences Alzheimer’s disease risk
    Salih, Dervis A, Bayram, Sevinc, Guelfi, Sebastian, Reynolds, Regina H, Shoai, Maryam, Ryten, Mina, Brenton, Jonathan W, Zhang, David, Matarin, Mar, Botia, Juan A et al. · 2019 · Brain Communications
  75. Changes in the Transcriptome of Human Astrocytes Accompanying Oxidative Stress-Induced Senescence
    Crowe, Elizabeth P., Tuzer, Ferit, Gregory, Brian D., Donahue, Greg, Gosai, Sager J., Cohen, Justin, Leung, Yuk Y., Yetkin, Emre, Nativio, Raffaella, Wang, Li-San et al. · 2016 · Frontiers in Aging Neuroscience
  76. The effect of LCZ696 (sacubitril/valsartan) on amyloid‐β concentrations in cerebrospinal fluid in healthy subjects
    Thomas Langenickel, Chiaki Tsubouchi, Surya P. Ayalasomayajula, Parasar Pal, Marie‐Anne Valentin, Markus Hinder, Stanford S. Jhee, Hakop Gevorkyan, Iris Rajman · 2015 · British Journal of Clinical Pharmacology
  77. Predicting gene targets from integrative analyses of summary data from GWAS and eQTL studies for 28 human complex traits
    Pavlides, Jennifer M. Whitehead, Zhu, Zhihong, Gratten, Jacob, McRae, Allan F., Wray, Naomi R., Yang, Jian · 2016 · Genome Medicine
  78. Large-scale genome-wide enrichment analyses identify new trait-associated genes and pathways across 31 human phenotypes
    Xiang Zhu, Matthew Stephens · 2018 · Nature Communications
  79. Alzheimer’s Disease: Biomarkers in the Genome, Blood, and Cerebrospinal Fluid
    Rose Ann Huynh, Chandra Mohan · 2017 · Frontiers in Neurology
  80. Identification of genes associated with dissociation of cognitive performance and neuropathological burden: Multistep analysis of genetic, epigenetic, and transcriptional data
    Charles C. White, Hyun‐Sik Yang, Lei Yu, Lori Beth Chibnik, Robert J. Dawe, Jingyun Yang, Hans‐Ulrich Klein, Daniel Felsky, Alfredo Ramos‐Miguel, Konstantinos Arfanakis et al. · 2017 · PLoS Medicine
  81. Reversal of synapse loss in Alzheimer mouse models by targeting mGluR5 to prevent synaptic tagging by C1Q
    Joshua M. Spurrier, LaShae Nicholson, Xiaotian T. Fang, Austin J. Stoner, Takuya Toyonaga, Daniel Holden, Timothy R. Siegert, Will Laird, Mary Alice Allnutt, Marius Chiasseu et al. · 2022 · Science Translational Medicine
  82. Binding Sites for Amyloid-β Oligomers and Synaptic Toxicity
    Levi M. Smith, Stephen M. Strittmatter · 2016 · Cold Spring Harbor Perspectives in Medicine
  83. Neuronal and glial 3D chromatin architecture informs the cellular etiology of brain disorders
    Hu, Benxia, Won, Hyejung, Mah, Won, Park, Royce B., Kassim, Bibi, Spiess, Keeley, Kozlenkov, Alexey, Crowley, Cheynna A., Pochareddy, Sirisha, The PsychENCODE Consortium et al. · 2021 · Nature Communications
  84. A general dimension of genetic sharing across diverse cognitive traits inferred from molecular data
    Javier de la Fuente, Gail Davies, Andrew David Grotzinger, Elliot M. Tucker–Drob, Ian J. Deary · 2020 · Nature Human Behaviour
  85. Insight into the genetic etiology of Alzheimer's disease: A comprehensive review of the role of rare variants
    Julie Hoogmartens, Rita Cacace, Christine Van Broeckhoven · 2021 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
  86. Microglial Exosomes in Neurodegenerative Disease
    Min Amy Guo, Yining Hao, Yiwei Feng, Haiqing Li, Yiting Mao, Qiang Dong, Mei Cui · 2021 · Frontiers in Molecular Neuroscience
  87. Prediction Models for Conversion From Mild Cognitive Impairment to Alzheimer’s Disease: A Systematic Review and Meta-Analysis
    Yanru Chen, Xiaoling Qian, Yuanyuan Zhang, Wenli Su, Yanan Huang, Xinyu Wang, Xiaoli Chen, Enhan Zhao, Lin Han, Yuxia Ma · 2022 · Frontiers in Aging Neuroscience
  88. Linking the Amyloid, Tau, and Mitochondrial Hypotheses of Alzheimer’s Disease and Identifying Promising Drug Targets
    Zdeněk Fišar · 2022 · Biomolecules
  89. Intracerebral adeno-associated virus gene delivery of apolipoprotein E2 markedly reduces brain amyloid pathology in Alzheimer's disease mouse models
    Zhao, Lingzhi, Gottesdiener, Andrew J., Parmar, Mayur, Li, Mingjie, Kaminsky, Stephen M., Chiuchiolo, Maria J., Sondhi, Dolan, Sullivan, Patrick M., Holtzman, David M., Crystal, Ronald G. et al. · 2016 · Neurobiology of Aging
  90. De novo deleterious genetic variations target a biological network centered on Aβ peptide in early-onset Alzheimer disease
    Rovelet-Lecrux, A, Charbonnier, C, Wallon, D, Nicolas, G, Seaman, M N J, Pottier, C, Breusegem, S Y, Mathur, P P, Jenardhanan, P, Le Guennec, K et al. · 2015 · Molecular Psychiatry
  91. Biomarkers in Sporadic and Familial Alzheimer’s Disease
    Lista, Simone, O’Bryant, Sid E., Blennow, Kaj, Dubois, Bruno, Hugon, Jacques, Zetterberg, Henrik, Hampel, Harald · 2015 · Journal of Alzheimer's Disease
  92. Substantial DNA methylation differences between two major neuronal subtypes in human brain
    Alexey Kozlenkov, Minghui Wang, Panos Roussos, Sergei Rudchenko, Mihaela Barbu, Marina V. Bibikova, Brandy Klotzle, Andrew J. Dwork, Bin Zhang, Yasmin L. Hurd et al. · 2015 · Nucleic Acids Research
  93. Pyk2 modulates hippocampal excitatory synapses and contributes to cognitive deficits in a Huntington’s disease model
    Giralt, Albert, Brito, Veronica, Chevy, Quentin, Simonnet, Clémence, Otsu, Yo, Cifuentes-Díaz, Carmen, de Pins, Benoit, Coura, Renata, Alberch, Jordi, Ginés, Sílvia et al. · 2017 · Nature Communications
  94. A 22‐single nucleotide polymorphism Alzheimer's disease risk score correlates with family history, onset age, and cerebrospinal fluid Aβ<sub>42</sub>
    Sleegers, Kristel, Bettens, Karolien, De Roeck, Arne, Van Cauwenberghe, Caroline, Cuyvers, Elise, Verheijen, Jan, Struyfs, Hanne, Van Dongen, Jasper, Vermeulen, Steven, Engelborghs, Sebastiaan et al. · 2015 · Alzheimer's &amp; Dementia
  95. <i>Lrrk2</i> alleles modulate inflammation during microbial infection of mice in a sex-dependent manner
    Shutinoski, Bojan, Hakimi, Mansoureh, Harmsen, Irene E., Lunn, Michaela, Rocha, Juliana, Lengacher, Nathalie, Zhou, Yi Yuan, Khan, Jasmine, Nguyen, Angela, Hake-Volling, Quinton et al. · 2019 · Science Translational Medicine
  96. The TMEM106B FTLD-protective variant, rs1990621, is also associated with increased neuronal proportion
    Li, Zeran, Farias, Fabiana H. G., Dube, Umber, Del-Aguila, Jorge L., Mihindukulasuriya, Kathie A., Fernandez, Maria Victoria, Ibanez, Laura, Budde, John P., Wang, Fengxian, Lake, Allison M. et al. · 2020 · Acta Neuropathologica
  97. Transcriptome-wide piRNA profiling in human brains of Alzheimer's disease
    Qiu, Wenying, Guo, Xiaoyun, Lin, Xiandong, Yang, Qian, Zhang, Wanying, Zhang, Yong, Zuo, Lingjun, Zhu, Yong, Li, Chiang-Shan R., Ma, Chao et al. · 2017 · Neurobiology of Aging
  98. Tau Overexpression Impacts a Neuroinflammation Gene Expression Network Perturbed in Alzheimer’s Disease
    Paul D. Wes, Amy E. Easton, John Corradi, Donna M. Barten, Nino Devidze, Lynn B. DeCarr, Amy B. Truong, Aiqing He, Nestor X. Barrezueta, Craig T. Polson et al. · 2014 · PLoS ONE
  99. Microglia in Alzheimer’s disease: A target for immunotherapy
    Shoutang Wang, Marco Colonna · 2019 · Journal of Leukocyte Biology
  100. ApoE4-Induced Cholesterol Dysregulation and Its Brain Cell Type-Specific Implications in the Pathogenesis of Alzheimer's Disease.
    Woojin Jeong, Hyein G. Lee, Sukhee Cho, Jinsoo Seo · 2019 · PubMed Central